WVU Surgeons First To Place Heart Valve Repair Device

MORGANTOWN — Surgeons at the West Virginia University Heart and Vascular Institute on Monday became the first in the United States to place the HAART 300 Aortic Annuloplasty Device, an aortic valve repair device invented by Heart and Vascular Institute surgeon J. Scott Rankin, M.D.

“Our surgeons are committed to offering patients the latest medical technologies that have the potential to improve patient outcomes,” said Vinay Badhwar, M.D., executive chair of the Heart and Vascular Institute. “We believe the HAART Aortic Annuloplasty Device fills a significant technological need that helps make aortic valve repair a simpler and more reproducible procedure to the benefit of patients.”

Badhwar, Rankin and Lawrence Wei, M.D., director of the Center for Aortic Valve Disease and co-director of the Center for Aortic Surgery, performed the first surgery on Monday followed by a second patient on Tuesday. Both received repair of their aortic valves with excellent results.

“The novel sizing method and simple, quick implantation technique for the HAART 300 Aortic Annuloplasty Device help to standardize the overall repair procedure,” Wei said. “Internal annuloplasty has significant advantages over existing aortic valve repair techniques and makes aortic valve repair a more attractive treatment option for a broader group of patients.”

The HAART 300 Aortic Annuloplasty Device, manufactured by BioStable Science & Engineering Inc., received Food and Drug Administration approval in March. It is the first commercially available internal annuloplasty device designed for the aortic valve.

According to WVU Medicine, annuloplasty is a procedure to reconstruct the frame, called the annulus, of a heart valve. It’s the preferred surgical treatment for valve diseases compared to valve replacement. The HAART 300 Aortic Annuloplasty Device is designed to re-size, reshape and stabilize the annulus of the aortic valve.

Because of the technical challenges of existing surgical techniques, aortic valve repair is performed routinely at only a limited number of heart centers around the world. This new device has the potential to become the surgical standard in aortic valve repair and make valve repair a more accessible option for patients.

COMMENTS